The closing price of Alterity Therapeutics Limited (NASDAQ: ATHE) was 0.50 for the day, down -10.71% from the previous closing price of $0.56. In other words, the price has decreased by $-0.0600 from its previous closing price. On the day, 1692651 shares were traded. ATHE reached its highest trading level at $0.6200 during the session, while it also had its lowest trading level at $0.4190.
Our analysis of ATHE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.10 and its Current Ratio is at 7.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.11 while its Price-to-Book (P/B) ratio in mrq is 0.85.
Stock Price History:
Over the past 52 weeks, ATHE has reached a high of $1.39, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 0.6012, while the 200-Day Moving Average is calculated to be 0.7309.
ATHE traded an average of 83.21K shares per day over the past three months and 199.13k shares per day over the past ten days. A total of 40.12M shares are outstanding, with a floating share count of 14.54M. Insiders hold about 18.70% of the company’s shares, while institutions hold 1.80% stake in the company. Shares short for ATHE as of Jul 14, 2022 were 259.25k with a Short Ratio of 2.60, compared to 173.19k on Jun 14, 2022.
The firm’s stock currently is rated by 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.